Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
We must make a concerted effort today to increase our capacity for timely development of safe, effective and innovative flu vaccines.
The United States' insufficient supply of H1N1 vaccines to inoculate our population demonstrates how poorly prepared we are to confront a pandemic.
We must begin to make our plans more broad-based to encompass the most threatening of pandemic scenarios.
We have made progress in pandemic preparedness, but we have a long way to go in ensuring a vibrant and responsive vaccine sector.
The future of medicine lies in DNA chips, supercomputers, and new drugs, not embryo research, tissue transplants, or stem cells.
Deliberately ignoring race in biomedical research can lead to inferior or improper treatment.
Discusses Jan/Feb issue of The American Enterprise.
